Please provide your email address to receive an email when new articles are posted on . A cost analysis of findings from the COLCOT trial showed that the addition of low-dose colchicine therapy to ...

Colchicine, when given in addition to conventional therapy, was more effective than placebo in reducing the incidence of recurrence and the persistence of symptoms of pericarditis in a randomised ...

Low-dose colchicine not only lowers the risk of ischemic CV events post-MI, it also can do so cost-effectively, according to the latest numbers from COLCOT. This is true from the perspective of the ...

Assistant Professor in Hospital Medicine, Northwestern University, Chicago, Ill. Colchicine has been previously shown to be effective in the prevention of recurrent pericarditis (Daily POEM; December ...

BASEL, Switzerland—Low-dose colchicine doesn’t significantly reduce MACE in patients who have had a nonsevere ischemic stroke or high-risk TIA, according to the results of the CONVINCE trial. Through ...

BASEL, SWITZERLAND — The anti-inflammatory agent colchicine failed to show significant benefit in the treatment of patients with non-cardioembolic ischemic stroke in the primary analysis of the ...